CYTOMX THERAPEUTICS INC's ticker is and the CUSIP is 23284F905. A total of 3 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,609 | -9.2% | 12,100 | +21.0% | 0.00% | – |
| Q2 2023 | $17,200 | +11290.7% | 10,000 | +9900.0% | 0.00% | – |
| Q1 2023 | $151 | -99.3% | 100 | -99.2% | 0.00% | – |
| Q4 2022 | $20,800 | +940.0% | 13,000 | +664.7% | 0.00% | – |
| Q3 2022 | $2,000 | – | 1,700 | +1600.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -80.0% | 0.00% | – |
| Q1 2022 | $1,000 | -92.3% | 500 | -83.9% | 0.00% | – |
| Q4 2021 | $13,000 | +116.7% | 3,100 | +158.3% | 0.00% | – |
| Q3 2021 | $6,000 | -33.3% | 1,200 | -14.3% | 0.00% | – |
| Q2 2021 | $9,000 | -18.2% | 1,400 | 0.0% | 0.00% | – |
| Q1 2021 | $11,000 | +83.3% | 1,400 | +75.0% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 800 | +166.7% | 0.00% | – |
| Q3 2018 | $6,000 | -57.1% | 300 | -50.0% | 0.00% | – |
| Q2 2018 | $14,000 | -89.1% | 600 | -86.7% | 0.00% | -100.0% |
| Q1 2018 | $128,000 | +509.5% | 4,500 | +350.0% | 0.00% | – |
| Q4 2017 | $21,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $151 | 0.00% |
| SIMPLEX TRADING, LLC | 54,600 | $82 | 0.00% |